SCHEMBL14429348

SCHEMBL14429348

CC(=O)OC[C@@H]1C[C@H](C)[C@@H](OC(C)=O)[C@@H](OC(C)=O)C(OC(C)=O)O1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.44
THRB P10828 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CA2 P00918 8/20 0.41
CA12 O43570 7/20 0.39
CA1 P00915 7/20 0.39
CA9 Q16790 7/20 0.39
OGA O60502 1/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 2/20 0.37
NR3C1 P04150 1/20 0.37
FYN P06241 1/20 0.37
ADRA2A P08913 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
ADRA2B P18089 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
PKM P14618 1/20 0.34
PTPN1 P18031 1/20 0.34
CA4 P22748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14429351 1.00 CYP2D6 (0.44) CYP2D6THRBHSD17B10CA2CA12
SCHEMBL14429364 0.87 CA9 (0.40) CYP2D6THRBHSD17B10CA2CA12
SCHEMBL26442139 0.86 CA2 (0.40) CYP2D6THRBHSD17B10CA2CA12
SCHEMBL8431811 0.84 CA2 (0.48) CYP2D6THRBHSD17B10CA2CA12
SCHEMBL20068297 0.84 CA2 (0.48) CYP2D6THRBHSD17B10CA2CA12
SCHEMBL13663076 0.84 CA2 (0.48) CYP2D6THRBHSD17B10CA2CA12
SCHEMBL26445085 0.84 CA2 (0.48) CYP2D6THRBHSD17B10CA2CA12
SCHEMBL11540698 0.84 CA2 (0.48) CYP2D6THRBHSD17B10CA2CA12
SCHEMBL8431814 0.84 CA2 (0.48) CYP2D6THRBHSD17B10CA2CA12
SCHEMBL26500775 0.84 CA2 (0.48) CYP2D6THRBHSD17B10CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185063-A1 Seven-membered ring nucleosides IDENIX PHARMACEUTICALS, INC. 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185063-A1 Seven-membered ring nucleosides NSUN2, NSUN3, HAVCR2 CYP2D6 1720/4885THRB 4696/4885HSD17B10 2101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.